Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-20

Clinical Trial Update: Paleolithic Diet in the Treatment of Glucose Intolerance [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes Phase 2 and Phase 3 studies evaluating a Paleolithic diet for treating glucose intolerance. The sponsor is Lund University …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lund University Hospital | Conditions: Hyperglycemia, Coronary Heart Disease | Phase 2, Phase 3 | Status: COMPLETED